Targeting CDK6 in cancer: State of the art and new insights

Cell Cycle
Solomon TadesseShudong Wang

Abstract

Cyclin-dependent kinase 6 (CDK6) plays a vital role in regulating the progression of the cell cycle. More recently, CDK6 has also been shown to have a transcriptional role in tumor angiogenesis. Up-regulated CDK6 activity is associated with the development of several types of cancers. While CDK6 is over-expressed in cancer cells, it has a low detectable level in non-cancerous cells and CDK6-null mice develop normally, suggesting a specific oncogenic role of CDK6, and that its inhibition may represent an ideal mechanism-based and low toxic therapeutic strategy in cancer treatment. Identification of selective small molecule inhibitors of CDK6 is thus needed for drug development. Herein, we review the latest understandings of the biological regulation and oncogenic roles of CDK6. The potential clinical relevance of CDK6 inhibition, the progress in the development of small-molecule CDK6 inhibitors and the rational design of potential selective CDK6 inhibitors are also discussed.

References

Mar 1, 1994·Molecular and Cellular Biology·M Meyerson, E Harlow
May 3, 1996·International Journal of Cancer. Journal International Du Cancer·K SatoH Ohgaki
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·J DeGregoriJ R Nevins
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts
Sep 30, 1999·The New England Journal of Medicine·B LöwenbergA Burnett
Apr 27, 2000·Nature Cell Biology·J W Harbour, D C Dean
Dec 22, 2000·Genes & Development·P D JeffreyN P Pavletich
Apr 19, 2002·Biochimica Et Biophysica Acta·Sagrario OrtegaMariano Barbacid
May 5, 2004·Chemistry & Biology·Campbell McInnesPeter M Fischer
Jun 5, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Toru OgasawaraHiroshi Kawaguchi
Jul 16, 2004·Molecular and Cellular Biology·Toru OgasawaraHiroto Okayama
Aug 28, 2004·Endocrinology·Maofu FuRichard G Pestell
Feb 4, 2005·Journal of Medicinal Chemistry·Heshu LuUrsula Schulze-Gahmen
Mar 2, 2005·Cell Cycle·Katarzyna Kozar, Piotr Sicinski
Mar 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jin T E LimI Bernard Weinstein
Apr 2, 2005·Journal of Medicinal Chemistry·Peter L ToogoodDavid W Fry
Apr 20, 2005·Oncogene·Desssislava K Dimova, Nicholas J Dyson
Apr 20, 2005·Oncogene·Amit DeshpandePhilip W Hinds
Oct 21, 2005·Trends in Biochemical Sciences·Marcos Malumbres, Mariano Barbacid
Nov 19, 2005·Journal of Cellular Biochemistry·Martha J Grossel, Philip W Hinds
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank MendrzykPeter Lichter
Apr 11, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Geoffrey I Shapiro
May 10, 2006·Bioorganic & Medicinal Chemistry Letters·Tadashi ShimamuraYoshikazu Iwasawa
Jun 20, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ruth SchwartzCornelis Murre
Jun 23, 2006·Journal of Medicinal Chemistry·Heshu Lu, Ursula Schulze-Gahmen
Jul 9, 2008·Journal of Neuro-oncology·Jessica PiersonRajeev Vibhakar
Sep 23, 2008·Trends in Cell Biology·Shirley Polager, Doron Ginsberg
Jan 27, 2009·Biochemical Pharmacology·Lindsay O Kirkland, Campbell McInnes
Feb 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·T TakakiM E M Noble
Feb 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Philip J DayHarren Jhoti

❮ Previous
Next ❯

Citations

Dec 17, 2015·Cancer Metastasis Reviews·Yunfei LiaoZhenfeng Duan
Apr 14, 2017·Cancer Investigation·Qi Zhou
Oct 28, 2017·Future Medicinal Chemistry·Jimma Likisa LenjisaShudong Wang
Nov 15, 2018·Journal of Cellular Biochemistry·Jia-Peng LiTong-Cun Zhang
Feb 28, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Heba S A ElzahabiMay A El-Manawaty
Mar 5, 2019·Molecular Genetics & Genomic Medicine·Kailibinuer AierkenGuzhalinuer Abulizi
Mar 21, 2019·Journal of Experimental & Clinical Cancer Research : CR·Zhe WangMargot Zöller
May 16, 2017·Laboratory Investigation; a Journal of Technical Methods and Pathology·Qi-Wen ZhaoXiu-Wu Bian
Apr 30, 2017·RNA·Shivani SharmaRitu Kulshreshtha
Aug 26, 2020·Cell Biology International·Xiujuan ShiJue Li
May 28, 2019·Molecular Neurobiology·Olivia Morris-HanonGuillermo Agustín Videla-Richardson
Oct 29, 2020·Chembiochem : a European Journal of Chemical Biology·Jessica SoamalalaMay C Morris
Nov 19, 2020·IScience·Gerwin HellerKaroline Kollmann
Feb 16, 2021·Journal of Cellular and Molecular Medicine·Changhao HuangLi Yang
Jul 25, 2020·European Journal of Medicinal Chemistry·Brilliant N MarakVed Prakash Singh
Sep 28, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tahir Ali ChohanMuhammad Sajid Hamid Akash
Jul 13, 2021·Frontiers in Cell and Developmental Biology·Ming HeYu Rao
May 16, 2020·Genomics, Proteomics & Bioinformatics·Ziyi LiX Shirley Liu
Jul 23, 2019·Journal of Medicinal Chemistry·Shang SuYu Rao

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
X-ray

Software Mentioned

PyMOL1

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.